Clinical feasibility is evolving. Instead of validating assumptions after a protocol is written, leading teams are embedding feasibility earlier—using real-world data and AI to iteratively pressure-test eligibility criteria, optimize study design, and build more recruitable protocols. In this session, TriNetX and Parexel share a modern feasibility workflow designed for clinical operations teams, including non-medical users empowered through natural language and AI translation. You’ll see how protocol criteria can be translated into executable queries, how “what-if” iteration improves protocol quality, and how feasibility insights can inform site and country strategies—faster and with more confidence.
Speakers
Senior Director, Clinical Feasibility
Parexel
Amy Spaziani is Director of Clinical Feasibility at Parexel, specializing in feasibility, site selection, and patient-centric trial design. She partners with sponsors to assess study viability, optimize recruitment strategies, and align protocols with real-world populations. Amy brings a decade of clinical research experience and contributes to advancing data-driven, inclusive trials.
